Selenium Modulates Cancer Cell Response to Pharmacologic Ascorbate

Connor S.R. Jankowski, Joshua D. Rabinowitz

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

High-dose ascorbate (vitamin C) has shown promising anticancer activity. Two redox mechanisms have been proposed: hydrogen peroxide generation by ascorbate itself or glutathione depletion by dehydroascorbate (formed by ascorbate oxidation). Here we show that the metabolic effects and cytotoxicity of high-dose ascorbate in vitro result from hydrogen peroxide independently of dehydroascorbate. These effects were suppressed by selenium through antioxidant selenoenzymes including glutathione peroxidase 1 (GPX1) but not the classic ferroptosis-inhibiting selenoenzyme GPX4. Selenium-mediated protection from ascorbate was powered by NADPH from the pentose phosphate pathway. In vivo, dietary selenium deficiency resulted in significant enhancement of ascorbate activity against glioblastoma xenografts. These data establish selenoproteins as key mediators of cancer redox homeostasis. Cancer sensitivity to free radical-inducing therapies, including ascorbate, may depend on selenium, providing a dietary approach for improving their anticancer efficacy.

Original languageEnglish (US)
Pages (from-to)3486-3498
Number of pages13
JournalCancer Research
Volume82
Issue number19
DOIs
StatePublished - Oct 1 2022

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Selenium Modulates Cancer Cell Response to Pharmacologic Ascorbate'. Together they form a unique fingerprint.

Cite this